STUDIES ON 9.2.27-4-DESACETYL VINBLASTINE-3-CARBOXYHYDRAZIDE (9.2.27-DAVLB-HYDRAZIDE) - PRECLINICAL PHARMACOLOGY AND TOXICOLOGY PROFILES FOR HUMAN-MELANOMA THERAPY

被引：0

|

作者：

BUMOL, TF ^{[1
]}

LAGUZZA, BC ^{[1
]}

BAKER, AL ^{[1
]}

TODD, GC ^{[1
]}

POHLAND, RC ^{[1
]}

APELGREN, LD ^{[1
]}

机构：

[1] ELI LILLY & CO,LILLY RES LAB,INDIANAPOLIS,IN 46285

来源：

PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：419 / 419

页数：1

相关论文

共 2 条

[1] PRECLINICAL DEVELOPMENT OF KS1/4-4-DESACETYL VINBLASTINE-3-CARBOXHYDRAZIDE (KS1/4-DAVLB-HYDRAZIDE) FOR SITE-DIRECTED THERAPY OF HUMAN ADENOCARCINOMAS
BUMOL, TF
LAGUZZA, BC
DEHERDT, SV
PARRISH, JE
ANDREWS, EL
ZIMMERMANN, JL
BAKER, AL
APELGREN, LD
JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 189 - 189
[2] KS1/4-4-DESACETYL VINBLASTINE-3-CARBOXHYDRAZIDE (KS1/4-DAVLB-HYDRAZIDE) - PRECLINICAL STUDIES ON A MONOCLONAL-ANTIBODY DRUG CONJUGATE FOR SITE-DIRECTED THERAPY OF HUMAN ADENOCARCINOMAS
BUMOL, TF
LAGUZZA, BC
DEHERDT, SV
PARRISH, JE
ANDREWS, EL
ZIMMERMANN, JL
BAKER, AL
MARDER, P
NICHOLS, CL
APELGREN, LD
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1987, 28 : 393 - 393